Home >> WEBINARS >> Resectability in Stage III NSCLC:
Case-Based Considerations for Clinical Decision Making

Resectability in Stage III NSCLC:
Case-Based Considerations for Clinical Decision Making

Print Friendly, PDF & Email

Wednesday, November 14, 2018, 1:00 pm–2:00 pm ET

Why should you register now for this webinar?

Hear national thought leaders discuss the following topics:

  • Updates to the AJCC staging guidelines for lung cancer, specifically Stage III disease
  • Rationales for determining resectability vs unresectability in Stage III disease
  • A summary of the NCCN treatment guidelines for Stage III NSCLC
  • The clinical decision-making process in an MDT setting for Stage III NSCLC
  • Brought to you by: CAP TODAY
  • Moderated by: Bob McGonnagle, Publisher, CAP TODAY
  • Presenters: Michael Walker, MD and Tracey Evans, MD

You will have the opportunity to ask questions of our distinguished presenters.

Presenters:

Michael Walker, MD
System Chief, Thoracic Surgery
Medical Director, Cancer Program
Main Line Health

Tracey Evans, MD
Director, Thoracic Oncology Research
Co-Director, Thoracic Oncology Program
Associate Program Director, Hematology/
Medical Oncology Fellowship Program
Lankenau Cancer Center
 
 
Register Now

 

CAP TODAY does not endorse any of the products or services named within.
©2018 AstraZeneca. All rights reserved.
US-23324 Last Updated 9/18

X